Deepthi Yedlapudi

Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model

Deepthi Yedlapudi, Gnanada S. Joshi, Dan Luo et al. · Scientific Reports · 2016 · 56 citations · Full text

Oxidants induce alternative splicing of α-synuclein: Implications for Parkinson's disease

Shasi V. Kalivendi, Deepthi Yedlapudi, Cecilia J. Hillard et al. · Free Radical Biology and Medicine · 2009 · 53 citations · Full text

Neurodegenerative Diseases, Biochemistry, Natural Sciences +8

Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson’s Disease

Asma S.mohamed Elmabruk, Banibrata Das, Deepthi Yedlapudi et al. · ACS Chemical Neuroscience · 2018 · 34 citations

Novel multifunctional dopamine D2/D3 receptors agonists with potential neuroprotection and anti-alpha synuclein protein aggregation properties

Dan Luo, Horrick Sharma, Deepthi Yedlapudi et al. · Bioorganic & Medicinal Chemistry · 2016 · 25 citations · Full text

Synthesis and Biological evaluation of novel 4β-[(5-substituted)-1,2,3,4-tetrazolyl] podophyllotoxins as anticancer compounds

Irfan Hyder, Deepthi Yedlapudi, Shasi V. Kalivendi et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 23 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +8